SCS
RAPP

Sound Capital Solutions’s Rapport Therapeutics RAPP Stock Holding History

Sound Capital Solutions’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Buy
+14,606
New +$537K 0.14% 106

Other funds holding RAPP

TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sound Capital Solutions's RAPP Position: Q2 2026 in Review

Sound Capital Solutions opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 14,606 shares worth $609K. The stake represents 0.14% of the portfolio and ranks #106 among its holdings.

146 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Sound Capital Solutions held 14,606 shares of Rapport Therapeutics worth $609K as of Q2 2026.
  • Rapport Therapeutics was a new Sound Capital Solutions position in Q2 2026.
  • Rapport Therapeutics made up 0.14% of Sound Capital Solutions's portfolio in Q2 2026, its #106 holding.
  • 146 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Sound Capital Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.